Combination therapy of radiation and intratumoral directo injection of dendritic cells for advanced esophageal cancer, a phase I study.
Not Applicable
- Conditions
- Esophageal cancer
- Registration Number
- JPRN-UMIN000011079
- Lead Sponsor
- Chiba University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1.Previous immunotehrapy, previous radiation therapy 2.Fistula 3.Obvious infection 4.Alb 3.0mg/ml or less 5.Uncontrolable pleural effusion, ascites, pericardial effusion 6.Severe heart failure 7.Respiratory or other complications 8.Psychological disorders 9.Active double cancers 10.Steroid usage 11.Hepatitis B or C. HIV, HTLV-1 positive 12.Hypersensitivity for albumin 13.Pregnant woman 14.Autoimmune diseases 16.Patients who cannot undergo apheresis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method